11-Dehydro Thromboxane B2/Creatinine Ratio

In recent years, there has been growing interest in identifying biomarkers that can provide accurate and reliable information about an individual's health status. 

The 11-Dehydro TXB2/Creatinine Ratio, which reflects the balance between thromboxane A2 (TXA2) synthesis and renal excretion, holds promise as a biomarker for assessing cardiovascular risk and renal function. 

Understanding the biochemical pathways and clinical relevance of the 11-Dehydro TXB2/Creatinine Ratio is essential for healthcare professionals to utilize it effectively in clinical practice.

Understanding 11-Dehydro TXB2/Creatinine Ratio

Definition and Overview

The 11-Dehydro TXB2/Creatinine Ratio represents the balance between thromboxane A2 (TXA2) synthesis and renal excretion. It is calculated by measuring the ratio of 11-dehydro thromboxane B2 (11-Dehydro TXB2) to creatinine levels in urine samples. 

This biomarker reflects the activity of thromboxane, a hormone involved in blood clotting and blood vessel constriction, and its elimination through the kidneys.

Definition of 11-Dehydro TXB2: What is 11-Dehydro TXB2?

11-Dehydro TXB2 is a metabolite of thromboxane A2, produced primarily by platelets and other cells in response to blood vessel injury or inflammation.  Thromboxane A2 is a potent platelet activator involved in thrombogenesis. 

11-dehydro-thromboxane B2 (11-dehydro-TXB2) is a urinary biomarker used to assess platelet activation and, by extension, clot formation which increases the risk of atherogenesis, myocardial infarction, and other cardiovascular events.  

Thromboxane B2 (TXB2), its stable and inactive precursor, reflects platelet activation levels and is sensitive to changes in cardiovascular and other atherothrombotic conditions. 

Elevated urinary levels of 11-dehydro-TXB2 can serve as a predictive tool not only for cardiovascular risks but also to monitor the effectiveness of antiplatelet therapy, such as aspirin. 

This marker's utility in tracking treatment efficacy stems from aspirin’s ability to reduce TXB2 formation, making it a valuable measure in managing patients with atherothrombotic diseases.

What is Creatinine?

Creatinine is a waste product of muscle metabolism, excreted at a regular rate by healthy kidneys. 

Creatinine is used to assess renal clearance because it is a stable endogenous substance produced at a constant rate by the body and is solely cleared by the kidneys, allowing for accurate measurement of kidney function.

What is the Clinical Significance of the 11-Dehydro TXB2/Creatinine Ratio?

The ratio of 11-Dehydro TXB2 to creatinine in urine provides insights into thromboxane synthesis and renal function, serving as an indicator of cardiovascular risk and kidney health.  It can be used to assess cardiovascular risk as well as monitor the effectiveness of anticoagulant therapy.  

Elevated ratios may indicate increased thromboxane synthesis, suggesting heightened cardiovascular risk or impaired renal function.  Additionally, urine 11-dehydro-thromboxane B2 is notably elevated in metabolic syndrome, particularly in those at high risk of atherosclerotic cardiovascular diseases.  [9.]

This elevation could identify candidates for aspirin therapy aimed at preventing cardiovascular events. Predictors of elevated 11-dehydro-TXB2 levels include factors like homocysteine, hs-CRP, adiponectin, and waist-to-hip ratio, along with total cholesterol levels.  [9.] 

Conversely, decreased ratios may reflect reduced thromboxane activity or enhanced renal excretion, indicating a lower risk of cardiovascular events and better kidney function.

Laboratory Testing for 11-Dehydro TXB2/Creatinine Ratio

Laboratory Test Information, Sample Type and Test Preparation

Laboratory testing for the 11-Dehydro TXB2/Creatinine Ratio typically involves analyzing urine samples to quantify the levels of 11-Dehydro TXB2 and creatinine. 

No special preparation is typically required, although urine samples that are too dilute cannot be processed.  It is essential to consult with the ordering provider regarding medication dosage and the use of blood-thinning supplements such as fish oil or green tea prior to obtaining a sample.  [1.] 

Interpretation of Test Results

Reference Range for 11-Dehydro TXB2/Creatinine Ratio 

The reference range for all ages is 

11-dhTXB2/Creatinine (pg/mg Cr): ≤1500  [1.] 

Clinical Significance of High 11-Dehydro TXB2/Creatinine Ratio 

A high 11-dehydro-thromboxane B2 (11-dehydro-TXB2)/creatinine ratio may signify the following:

Platelet Activation: elevated levels may indicate increased platelet activation, common in various cardiovascular conditions.

Cardiovascular Diseases: elevations may signal atherosclerosis or peripheral artery disease, where platelet activation plays a key role in disease progression.  [9.] 

Metabolic Syndrome: particularly in individuals with obesity, hypertension, or diabetes, where increased platelet reactivity is observed.  [9.] 

‍Inflammation: chronic inflammatory states can enhance platelet activation and thromboxane production.  [9.] 

Inadequate Aspirin Therapy: in patients on aspirin therapy, insufficient suppression of platelet function can result in elevated levels.  [1.] 

Smoking: active smoking can increase platelet activation and hence thromboxane levels.

Kidney Dysfunction: Impaired renal clearance can elevate the creatinine-normalized levels of urine biomarkers, including 11-dehydro-TXB2.

Clinical Significance of Low 11-Dehydro TXB2/Creatinine Ratio 

Lower 11-dehydro TXB2/Creatinine ratios are associated with normal platelet function and decreased risk of cardiovascular events.  [9.] 

Testing Biomarkers Related to 11-Dehydro TXB2/Creatinine Ratio

Biomarkers to consider in conjunction with 11-dehydro TXB2/creatinine ratio include:

Homocysteine

Elevated homocysteine levels can increase platelet activity and are associated with cardiovascular diseases. It can provide insights into the risk of thrombosis in conjunction with 11-dehydro TXB2.  [9.] 

High-sensitivity C-reactive protein (hsCRP) 

hsCRP is an indicator of cardiovascular inflammation and is associated with cardiovascular risk. Its measurement alongside 11-dehydro TXB2 can help assess overall cardiovascular inflammation and potential for atherothrombosis.  [9.] 

Fibrinogen

Fibrinogen is a key factor in clot formation and its levels can indicate the propensity for thrombotic events. Elevated fibrinogen can complement high 11-dehydro TXB2 levels in indicating increased thrombotic risk.  [7.] 

Prothrombin Time/International Normalized Ratio (PT/INR)

PT/INR assesses the clotting tendency of blood; testing it with 11-dehydro TXB2 can help evaluate the balance of thrombotic risk and anticoagulation status, especially in patients on anticoagulant therapy.

Lipid Panel

Lipids can influence platelet reactivity and thromboxane production. Assessing lipid levels can help in managing overall cardiovascular risk and tailor lipid-lowering therapy, especially in conjunction with a patient’s overall health history.  [6.]

Comprehensive Metabolic Panel (CMP)

CMP includes kidney and liver function tests which are essential to evaluate before prescribing medications that affect platelet function or thromboxane production, ensuring safe medication use based on metabolic health.  

Other markers of renal function such as blood urea nitrogen (BUN) and serum creatinine are commonly measured to assess kidney health.  Monitoring these renal function markers alongside the 11-Dehydro TXB2/Creatinine Ratio enhances the evaluation of cardiovascular risk and kidney health, facilitating comprehensive patient assessment and management.

These tests, combined with 11-dehydro TXB2, provide a comprehensive view of a patient's thrombotic and cardiovascular health, aiding in more precise and targeted management.

Natural Ways to Optimize 11-Dehydro TXB2/Creatinine Ratio

A healthy balance of blood clotting and blood thinning is the foundation of healthy platelet function.  This begins with reducing inflammation and optimizing nutrition.

• Adopt an anti-inflammatory diet such as the Mediterranean diet, which is rich in fruits, vegetables, whole grains, and healthy fats such as omega-3 fatty acids.  The Mediterranean diet has many well-known benefits for cardiovascular health, although its effects on venous thrombosis are not fully elucidated.  [11.] 

• Maintain a healthy weight through regular exercise and portion control to reduce excess inflammation associated with obesity.  [4.] 

• Avoid processed foods, refined sugars, and excessive consumption of saturated and trans fats, which can promote inflammation.  [3.] 

• Incorporate natural anti-inflammatory supplements such as turmeric, ginger, and omega-3 fatty acids into your diet.  [5., 13.]

• Ensure adequate sleep, aiming for 7-9 hours per night, as insufficient sleep can contribute to inflammation and clotting.  [2.]

• Limit alcohol consumption, as excessive alcohol intake can increase inflammation and disrupt normal blood clotting mechanisms.  [8.] 

• Quit smoking, as smoking not only increases inflammation but also damages blood vessels and promotes clot formation.  [8.] 

• Consider consulting with a healthcare professional for assessment of blood clotting status and to explore pharmaceutical options for reducing inflammation and clotting, if necessary, based on individual health needs and risk factors.

Order 11-Dehydro TXB2/Creatinine Ratio Testing

Click here to compare testing options and order testing for 11-Dehydro TXB2/Creatinine ratio.